Centre de Génétique et Centre de Référence, Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU Dijon, Dijon, France.
J Med Genet. 2012 Jun;49(6):400-8. doi: 10.1136/jmedgenet-2012-100856.
Non-progressive congenital ataxias (NPCA) with or without intellectual disability (ID) are clinically and genetically heterogeneous conditions. As a consequence, the identification of the genes responsible for these phenotypes remained limited.
Identification of a new gene responsible for NPCA and ID. Methods Following the discovery of three familial or sporadic cases with an intragenic calmodulin-binding transcription activator 1 (CAMTA1) rearrangement identified by an array-CGH and recruited from a national collaboration, the authors defined the clinical and molecular characteristics of such rearrangements, and searched for patients with point mutations by direct sequencing.
Intragenic copy number variations of CAMTA1 were all located in the CG-1 domain of the gene. It segregated with autosomal dominant ID with non-progressive congenital cerebellar ataxia (NPCA) in two unrelated families, and was de novo deletion located in the same domain in a child presenting with NPCA. In the patients with ID, the deletion led to a frameshift, producing a truncated protein, while this was not the case for the patient with isolated childhood ataxia. Brain MRI of the patients revealed a pattern of progressive atrophy of cerebellum medium lobes and superior vermis, parietal lobes and hippocampi. DNA sequencing of the CG-1 domain in 197 patients with sporadic or familial non-syndromic intellectual deficiency, extended to full DNA sequencing in 50 patients with ID and 47 additional patients with childhood ataxia, identified no pathogenic mutation.
The authors have evidence that loss-of-function of CAMTA1, a brain-specific calcium responsive transcription factor, is responsible for NPCA with or without ID. Accession numbers CAMTA1 reference sequence used was ENST00000303635. Protein sequence was ENSP00000306522.
伴有或不伴智力障碍(ID)的非进行性先天性共济失调(NPCA)是临床和遗传上具有异质性的疾病。因此,导致这些表型的基因鉴定仍然有限。
鉴定一个新的 NPCA 和 ID 相关基因。方法:在通过 array-CGH 发现三个家族性或散发性病例存在钙调蛋白结合转录激活因子 1(CAMTA1)基因内重排,并且招募到国家合作项目后,作者确定了此类重排的临床和分子特征,并通过直接测序寻找点突变患者。
CAMTA1 的基因内拷贝数变化均位于该基因的 CG-1 结构域内。在两个不相关的家族中,与常染色体显性 ID 伴非进行性先天性小脑共济失调(NPCA)共分离,在一名患有 NPCA 的儿童中,该缺失是从头发生于同一结构域的缺失。在 ID 患者中,缺失导致移码,产生截短的蛋白,而孤立性儿童共济失调患者则不是这种情况。患者的脑 MRI 显示小脑中叶和上蚓部、顶叶和海马进行性萎缩的模式。在 197 名散发或家族性非综合征性智力低下患者的 CG-1 结构域中进行 DNA 测序,扩展至 50 名 ID 患者和 47 名额外的儿童共济失调患者的全长 DNA 测序,未发现致病性突变。
作者有证据表明,脑特异性钙反应转录因子 CAMTA1 的功能丧失与 NPCA 伴或不伴 ID 有关。CAMTA1 参考序列的注册号为 ENST00000303635。蛋白序列为 ENSP00000306522。